Pfizer’s $2.3B Bextra Fraud Fine

In 2005, Pharmacia & Upjohn Company Inc., a subsidiary of Pfizer, was fined $2.3 billion for defrauding the FDA by wrongfully promoting Bextra, an anti-inflammatory drug.

Previous Fact Next Fact